Nanomedicine is literally a new age term encompassing all the applications that use new technological nano-technology. It is a general term for any new or emerging technology that uses small particles for medical and other purposes. Nanotechnology is also used to develop drugs that can attack and kill cancer cells without harming healthy cells. Nanomedicine has opened up new horizons for healthcare and medicines. It has opened up new ways for the drug delivery systems and it has enabled the development of nanomedicines. Hence we can say that nanotechnology is not just about producing and using
Global Nanomedicine Market: Drivers
High prevalence of chronic diseases is expected to propel growth of the global nanomedicine market. For instance, according to the study, ‘Cancer statistics for adults aged 85 years and older, 2019’, published in ACS CA: A Cancer Journal for Clinicians, in August 2019, in 2019, the projected number of cancer cases and deaths was 140,690 and 103,250 respectively, among adults aged 85 years and older in the U.S.
Global Nanomedicine Market: Opportunities
Increasing funding in nanomedicine is expected to offer lucrative growth opportunities for players in the global nanomedicine market. For instance, in August 2020, Clene Nanomedicine, Inc. raised US$ 42.5 million in a Series D financing.
Global Nanomedicine Market: Recent Developments
Major players in the are focused on adopting partnership strategies to expand their product portfolio. For instance, in June 2020, Sirnaomics Inc. partnered with Precision NanoSystems Inc. for development and manufacture of Sirnaomics polypeptide nanoparticle-based RNAi therapeutic product.
Global Nanomedicine Market: Restraints
High cost of R&D and manufacturing is expected to hinder growth of the global nanomedicine market.
Covid-19 Impact Analysis:
Globally, as of 5:09pm CEST, 20 October 2021, there have been 241,411,380 confirmed cases of COVID-19, including 4,912,112 deaths, reported to WHO. As of 19 October 2021, a total of 6,545,309,084 vaccine doses have been administered. Nanomedicine finds application in R&D of drugs for Covid-19. For instance, in May 2020, NanoViricides, Inc. announced that strong effectiveness against infection by an ACE2-utilizing coronavirus in an animal model has been observed for the drug candidates it is developing against SARS-CoV-2 to treat COVID-19 spectrum of diseases.
Increasing development of nanomedicines is expected to propel growth of the global nanomedicine market over the forecast period. For instance, in June 2020, Sirnaomics Inc. partnered with Precision NanoSystems Inc. for development and manufacture of Sirnaomics polypeptide nanoparticle-based RNAi therapeutic product.
Global Nanomedicine Market: Competitive Landscape
Major players operating in the global nanomedicine market include, NanoViricides, Inc., Johnson & Johnson, GE Healthcare, Mallinckrodt plc., Celgene Corporation, Sirnaomics Inc., Precision NanoSystems Inc., Nanobiotix S.A, Merck & Company Inc., Cellics Therapeutics, Inc., Nanosphere, Inc., Clene Nanomedicine, Inc., Pfizer Inc., CombiMatrix Corporation, Sigma-Tau Pharmaceuticals Inc., and Abbott Laboratories.
Global Nanomedicine Market: Key Developments
Major players operating in the global nanomedicine market are focused on adopting partnership strategies to enhance their market share. For instance, in April 2020, Evotec SE, a drug discovery and development company, partnered with leon-nanodrugs GmbH, a company that focuses on the reformulation of approved or promising small molecule and protein drug candidates, for R&D in maximizing the effectiveness of clinical and commercial nanomedicines.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Nanomedicines Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Nanomedicines Industry Impact
Chapter 2 Global Nanomedicines Competition by Types, Applications, and Top Regions and Countries
2.1 Global Nanomedicines (Volume and Value) by Type
2.3 Global Nanomedicines (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Nanomedicines Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Nanomedicines Market Analysis
Chapter 6 East Asia Nanomedicines Market Analysis
Chapter 7 Europe Nanomedicines Market Analysis
Chapter 8 South Asia Nanomedicines Market Analysis
Chapter 9 Southeast Asia Nanomedicines Market Analysis
Chapter 10 Middle East Nanomedicines Market Analysis
Chapter 11 Africa Nanomedicines Market Analysis
Chapter 12 Oceania Nanomedicines Market Analysis
Chapter 13 South America Nanomedicines Market Analysis
Chapter 14 Company Profiles and Key Figures in Nanomedicines Business
Chapter 15 Global Nanomedicines Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027